Explore federal awards
Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
Export these results to CSV · 16 matching records
TO PROVIDE MONITORING SERVICES FOR ONE (1) PHASE III CLINICAL TRIAL, A5300B/PHOENIXDepartment of Health and Human Services$5.7M obligationsEnds Dec 14, 2025
COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMSDepartment of Health and Human Services$0 obligationsEnds Aug 31, 2022
R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH)Department of Health and Human Services$21.9M obligationsEnds Oct 31, 2021
TAS::75 0885::TAS NIAID DAIT CLINICAL SITE MONITORING CENTERDepartment of Health and Human Services$27.0M obligationsEnds Aug 20, 2026
COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS)Department of Health and Human Services$26.1M obligationsEnds Aug 14, 2027
REGULATORY MANAGEMENT CENTER (RMC)Department of Health and Human Services$17.4M obligationsEnds Oct 31, 2026
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) CLINICAL SITE MONITORING CENTER (CSMC)Department of Health and Human Services$36.4M obligationsEnds Jun 29, 2027
NIAID CLINICAL SITE MONITORING (NCSM)Department of Health and Human Services$73.2M obligationsEnds Jan 31, 2027
TASK ORDER 75N93022F00001 BASE AWARDDepartment of Health and Human Services$905.5K obligationsEnds Jan 13, 2027
DAIDS MONITORING FOR 1 PHASE III STUDY: A5300B/I2003B (PHOENIX)Department of Health and Human Services$3.1M obligationsEnds Dec 14, 2026
EPCTUDepartment of Health and Human Services$2.8M obligationsEnds Jan 31, 2026
IGF::OT::IGF NIAID HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS)Department of Health and Human Services$329.8M obligationsEnds Aug 14, 2024
COVID 19. THIS TASK ORDER IS TO PROVIDE COMPREHENSIVE/FULL CLINICAL TRIAL MANAGEMENT SUPPORT SERVICES TO THE ONGOING ACTIV-2 CLINICAL TRIAL. THE CONTRACTOR SHALL COMPLY WITH…Department of Health and Human Services$34.6M obligationsEnds Nov 5, 2022
IGF::OT::IGF NIAID CLINICAL SITE MONITORINGDepartment of Health and Human Services$135.1M obligationsEnds Jan 31, 2024
"COVID 19"COMPLETION OF ACTIV 2 STUDYDepartment of Health and Human Services$64.0M obligationsEnds Aug 31, 2025
THE CONTINUUM OF CARE IN HOSPITALIZED PATIENTS WITH OPIOID USE DISORDER AND INFECTIOUS COMPLICATIONS OF DRUG USE (CHOICE)Department of Health and Human Services$2.3M obligationsEnds Mar 22, 2024